Numerai’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$825K Buy
8,594
+808
+10% +$82.8K 0.07% 445
2026
Q1
$850K Buy
7,786
+725
+10% +$69.1K 0.09% 382
2025
Q4
$573K Buy
+7,061
New +$608K 0.07% 372

Other funds holding LMAT

Numerai's LMAT Position: Q2 2026 in Review

Numerai increased its LeMaitre Vascular (LMAT) stake by 10% in Q2 2026, buying an estimated $82.8K and bringing the position to 8,594 shares worth $825K. The position accounts for 0.07% of the portfolio, ranked #445.

Numerai first reported a position in LMAT in Q4 2025 and has held it in 3 quarters since. The position peaked at $850K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Numerai held 8,594 shares of LeMaitre Vascular worth $825K as of Q2 2026.
  • Numerai bought 808 LeMaitre Vascular shares in Q2 2026, an estimated $82.8K.
  • LeMaitre Vascular made up 0.07% of Numerai's portfolio in Q2 2026, its #445 holding.
  • Numerai first reported a position in LeMaitre Vascular in Q4 2025 and has held it in 3 quarters since.
  • Numerai's LeMaitre Vascular position peaked at $850K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.